You are here

Error message

We are currently having some connectivity issues with our membership database; functionality that relies on this connection will not work. The issue is being looked at. Apologies for any inconvenience caused.

COLLABORATION RAISES HOPE FOR MEN WITH RECURRENT PROSTATE CANCER

22 July 2013

The College of Radiographers (CoR) has joined forces with Prostate Cancer UK to award a Clinical Training Fellowship worth over £180,000, with support from the Movember Foundation. 

The winning proposal gives hope of eventual focused therapy for men with recurrent (returned) prostate cancer.

One of the main barriers to curative treatment of recurrent prostate cancer is that it can’t yet be effectively targeted; all available therapies affect the whole prostate gland – rather than just the part with the cancer – and frequently result in severe side effects that dramatically reduce quality of life.

Currently, radiographic imaging techniques like Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) are most commonly used after prostate cancer diagnosis. Both techniques are used to image the pelvis area, including the prostate, to determine whether the cancer has spread and what the most effective treatment might be.

However, these sophisticated imaging techniques have the potential to see the location of the cancer more precisely, which could have an impact on treating recurrent prostate cancer. 

New Fellow set to break down barriers

In this highly competitive joint Training Fellowship, Mr James Stirling, the new Fellow and lead research radiographer at the Paul Strickland Scanner Centre, will look at using technology to break throught the ‘brick wall’ we’ve hit in identifying further treatment for men with recurrent prostate cancer. He will use data obtained from currently available imaging technologies, and analyse it in a new way. 

This advanced technique, called textural analysis, will turn the separate information from each imaging technique into a detailed map of the prostate, showing precisely where the cancerous and normal tissue is. 

This will allow the researchers to get more precise and detailed information about the extent of cancer within the prostate than has ever been gained before – much more than can be gained by looking at any imaging technique on its own.

This technique could help identify those men likely to benefit from existing treatment and reduce unnecessary therapy and side-effects for men whose prostate cancer poses a lower risk. It could also be used to accurately pinpoint the cancer’s location within the prostate, allowing the use of targeted therapies, which would likely also reduce the severity of any side effects.

Dr Iain Frame, Director of Research at Prostate Cancer UK said: ‘We are extremely proud to launch the first Fellowship award under our exciting new partnership with the College of Radiographers. With the support of our partners, the Movember Foundation, we have committed to fund research that will make a difference to men, and this partnership opens up a great way for us to do this – by supporting clinicians who are working on the ground with men with prostate cancer to give them the best possible care and support, both now and in the future.

"We are extremely grateful to the College of Radiographers for their support, and we hope this really sets a good example for how we can work in partnership with other organisations to achieve the best results for men with prostate cancer.’

The preliminary data in this project proposal is extremely encouraging, and we are very much looking forward to the results of this study.

The next call for Prostate Cancer UK - College of Radiographers Clinical Training Fellowships is now open!

Notes for Editor

The Society and College of Radiographers is the professional body for radiographers and all non-medical members of the workforce in diagnostic imaging and radiotherapy in the UK. It is responsible for their professional, educational, public and workplace interests. The College's objects are directed towards education, research and other activities in support of the science and practice of radiography. For more information, please contact Prostate Cancer UK’s press office on 0208 222 7633.

Content tools

Accessibility controls

Text size

AA A

Colour